These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22273841)

  • 1. Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model.
    Fukami N; Ramachandran S; Narayanan K; Liu W; Nath DS; Jendrisak M; Chapman W; Mohanakumar T
    Transplantation; 2012 Feb; 93(4):364-72. PubMed ID: 22273841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.
    Sharma M; Webber SA; Zeevi A; Mohanakumar T
    Hum Immunol; 2019 Apr; 80(4):248-256. PubMed ID: 30710563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
    Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
    J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model.
    Seemampillai B; Germack R; Felkin LE; McCormack A; Rose ML
    Transplantation; 2014 Jul; 98(1):29-38. PubMed ID: 24879379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.
    Jordan SC; Quartel AW; Czer LS; Admon D; Chen G; Fishbein MC; Schwieger J; Steiner RW; Davis C; Tyan DB
    Transplantation; 1998 Sep; 66(6):800-5. PubMed ID: 9771846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
    Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N
    Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
    Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
    Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
    Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
    Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
    Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.
    Wang H; Arp J; Liu W; Faas SJ; Jiang J; Gies DR; Ramcharran S; Garcia B; Zhong R; Rother RP
    J Immunol; 2007 Oct; 179(7):4451-63. PubMed ID: 17878341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.